Abletshauser C - Search Results

1

A randomized, double-blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY Study.

Riess H, Haas S, Tebbe U, Gerlach HE, Abletshauser C, Sieder C, Rossol S, Pfeiffer B, Schellong SM. Riess H, et al. Among authors: abletshauser c. J Thromb Haemost. 2010 Jun;8(6):1209-15. doi: 10.1111/j.1538-7836.2010.03848.x. Epub 2010 Mar 9. J Thromb Haemost. 2010. PMID: 20218984 Free article. Clinical Trial.

2

An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN.

Schellong SM, Haas S, Greinacher A, Schwanebeck U, Sieder C, Abletshauser C, Bramlage P, Riess H. Schellong SM, et al. Among authors: abletshauser c. Expert Opin Pharmacother. 2010 Dec;11(18):2953-61. doi: 10.1517/14656566.2010.521498. Epub 2010 Oct 18. Expert Opin Pharmacother. 2010. PMID: 20950224 Clinical Trial.

3

Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: a subgroup analysis of the randomized, controlled CERTIFY study.

Tebbe U, Schellong SM, Haas S, Gerlach HE, Abletshauser C, Sieder C, Bramlage P, Riess H. Tebbe U, et al. Among authors: abletshauser c. Am Heart J. 2011 Feb;161(2):322-8. doi: 10.1016/j.ahj.2010.10.005. Am Heart J. 2011. PMID: 21315215 Clinical Trial.

4

Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY.

Haas S, Schellong SM, Tebbe U, Gerlach HE, Bauersachs R, Melzer N, Abletshauser C, Sieder C, Bramlage P, Riess H. Haas S, et al. Among authors: abletshauser c. BMC Cancer. 2011 Jul 26;11:316. doi: 10.1186/1471-2407-11-316. BMC Cancer. 2011. PMID: 21791091 Free PMC article. Clinical Trial.

5

CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency.

Bauersachs R, Schellong SM, Haas S, Tebbe U, Gerlach HE, Abletshauser C, Sieder C, Melzer N, Bramlage P, Riess H. Bauersachs R, et al. Among authors: abletshauser c. Thromb Haemost. 2011 Jun;105(6):981-8. doi: 10.1160/TH10-09-0614. Epub 2011 Apr 20. Thromb Haemost. 2011. PMID: 21505722 Clinical Trial.

6

Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: an analysis of the CERTIFY study.

Schellong SM, Gerlach HE, Tebbe U, Haas S, Melzer N, Abletshauser C, Sieder C, Bramlage P, Riess H, Bauersachs R. Schellong SM, et al. Among authors: abletshauser c. Thromb Res. 2011 Nov;128(5):417-21. doi: 10.1016/j.thromres.2011.05.002. Epub 2011 Jun 11. Thromb Res. 2011. PMID: 21658750 Clinical Trial.

7

The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment.

Riegger G, Abletshauser C, Ludwig M, Schwandt P, Widimsky J, Weidinger G, Welzel D. Riegger G, et al. Among authors: abletshauser c. Atherosclerosis. 1999 May;144(1):263-70. doi: 10.1016/s0021-9150(99)00062-3. Atherosclerosis. 1999. PMID: 10381299 Clinical Trial.

8

Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor.

Huhle G, Abletshauser C, Mayer N, Weidinger G, Harenberg J, Heene DL. Huhle G, et al. Among authors: abletshauser c. Thromb Res. 1999 Sep 1;95(5):229-34. doi: 10.1016/s0049-3848(99)00037-7. Thromb Res. 1999. PMID: 10515287 Clinical Trial.

9

Beneficial effects of fluvastatin on myocardial blood flow at two time-points in hypercholesterolemic patients with coronary artery disease.

Eichstädt HW, Abletshauser CB, Störk T, Weidinger G. Eichstädt HW, et al. Among authors: abletshauser cb. J Cardiovasc Pharmacol. 2000 May;35(5):735-40. doi: 10.1097/00005344-200005000-00009. J Cardiovasc Pharmacol. 2000. PMID: 10813375 Clinical Trial.

10

A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease.

Rothe G, Herr AS, Stöhr J, Abletshauser C, Weidinger G, Schmitz G. Rothe G, et al. Among authors: abletshauser c. Atherosclerosis. 1999 May;144(1):251-61. doi: 10.1016/s0021-9150(99)00061-1. Atherosclerosis. 1999. PMID: 10381298 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters